Elelyso

PreclinicalSmall molecule

SShaare Zedek Medical Center

Elelyso is one of 7 small molecule programs targeting Bone. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

BoneCompleted

BonePreclinical

Completed

Competition

Competitive Landscape

11 competitors in Bone

#DrugCompanyPhaseTrials

Invanz

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

1 2

BOOST Cells

KKarolinska Institutet

Phase 2

1 3

Bone Marrow Aspirate Concentrate

MMassachusetts General Hospital

Preclinical

2 4

Platelet-Rich Fibrin (PRF)

FFederal University of São Paulo

Preclinical

1 5

Vertebral Bone Marrow Clot

IIstituto Ortopedico Rizzoli

Preclinical

1 6

Elelyso

SShaare Zedek Medical Center

Preclinical

1 7

Puregen Osteoprogenitor Cell Allograft

AAlphatec Spine, Inc.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Gaucher Disease1 trial

A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease

Completed·AAri Zimran·Phase 4·NCT04002830·14 enrolled

Bone1 trial

Assessing the Impact of Elelyso on Bone Involvement Currently Treated With Other ERTs

Completed·SShaare Zedek Medical Center·N/A·NCT04353466·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Elelyso. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Elelyso compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Elelyso. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Shaare Zedek Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: SShaare Zedek Medical Center

Elelyso

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Gaucher Disease1 trial

Bone1 trial

References

Drug Info

Quick Facts

Related News